Wealthfront Advisers’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.4M | Sell |
43,704
-4,284
| -9% | -$1.87M | 0.03% | 185 |
|
|
2026
Q1 | $22.1M | Buy |
47,988
+1,732
| +4% | +$876K | 0.05% | 129 |
|
|
2025
Q4 | $26.2M | Buy |
46,256
+6,180
| +15% | +$3.29M | 0.06% | 110 |
|
|
2025
Q3 | $17.9M | Sell |
40,076
-6,091
| -13% | -$2.92M | 0.04% | 135 |
|
|
2025
Q2 | $25.1M | Buy |
46,167
+1,481
| +3% | +$774K | 0.06% | 97 |
|
|
2025
Q1 | $22.1M | Buy |
44,686
+770
| +2% | +$426K | 0.06% | 99 |
|
|
2024
Q4 | $22.9M | Buy |
43,916
+2,777
| +7% | +$1.45M | 0.07% | 88 |
|
|
2024
Q3 | $20.2M | Buy |
41,139
+766
| +2% | +$357K | 0.06% | 87 |
|
|
2024
Q2 | $18M | Buy |
40,373
+561
| +1% | +$223K | 0.06% | 90 |
|
|
2024
Q1 | $15.9M | Buy |
39,812
+891
| +2% | +$337K | 0.06% | 100 |
|
|
2023
Q4 | $13.1M | Buy |
38,921
+3,106
| +9% | +$926K | 0.05% | 109 |
|
|
2023
Q3 | $10.5M | Sell |
35,815
-79
| -0.2% | -$24.7K | 0.05% | 118 |
|
|
2023
Q2 | $12.3M | Buy |
35,894
+5,984
| +20% | +$1.81M | 0.05% | 99 |
|
|
2023
Q1 | $7.64M | Sell |
29,910
-10,612
| -26% | -$2.61M | 0.03% | 148 |
|
|
2022
Q4 | $10.8M | Buy |
40,522
+22,172
| +121% | +$5.41M | 0.05% | 109 |
|
|
2022
Q3 | $3.44M | Buy |
18,350
+2,064
| +13% | +$443K | 0.02% | 248 |
|
|
2022
Q2 | $3.27M | Sell |
16,286
-5,820
| -26% | -$1.37M | 0.02% | 270 |
|
|
2022
Q1 | $6.67M | Buy |
22,106
+6,531
| +42% | +$1.91M | 0.03% | 162 |
|
|
2021
Q4 | $5.6M | Buy |
15,575
+3,110
| +25% | +$1.07M | 0.02% | 177 |
|
|
2021
Q3 | $4.13M | Buy |
12,465
+2,913
| +30% | +$978K | 0.02% | 187 |
|
|
2021
Q2 | $2.93M | Buy |
9,552
+1,791
| +23% | +$502K | 0.01% | 226 |
|
|
2021
Q1 | $1.91M | Buy |
7,761
+270
| +4% | +$67.9K | 0.01% | 275 |
|
|
2020
Q4 | $2.04M | Buy |
7,491
+327
| +5% | +$81.2K | 0.01% | 227 |
|
|
2020
Q3 | $1.69M | Buy |
7,164
+93
| +1% | +$20.9K | 0.01% | 213 |
|
|
2020
Q2 | $1.34M | Sell |
7,071
-168
| -2% | -$30.1K | 0.01% | 249 |
|
|
2020
Q1 | $1.2M | Sell |
7,239
-1,908
| -21% | -$349K | 0.01% | 239 |
|
|
2019
Q4 | $1.8M | Buy |
9,147
+246
| +3% | +$46.1K | 0.01% | 203 |
|
|
2019
Q3 | $1.6M | Buy |
8,901
+198
| +2% | +$34.2K | 0.01% | 201 |
|
|
2019
Q2 | $1.52M | Sell |
8,703
-1,776
| -17% | -$304K | 0.01% | 195 |
|
|
2019
Q1 | $1.99M | Buy |
10,479
+1,251
| +14% | +$222K | 0.02% | 146 |
|
|
2018
Q4 | $1.47M | Buy |
+9,228
| New | +$1.56M | 0.02% | 176 |
|
Other funds holding ISRG
Wealthfront Advisers's ISRG Position: Q2 2026 in Review
Wealthfront Advisers reduced its Intuitive Surgical (ISRG) stake by 8.9% in Q2 2026, selling an estimated $1.87M and leaving 43,704 shares worth $17.4M. The position accounts for 0.03% of the portfolio, ranked #185.
Wealthfront Advisers first reported a position in ISRG in Q4 2018 and has held it in 31 quarters since. The position peaked at $26.2M in Q4 2025. 2,251 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.
- Wealthfront Advisers held 43,704 shares of Intuitive Surgical worth $17.4M as of Q2 2026.
- Wealthfront Advisers sold 4,284 Intuitive Surgical shares in Q2 2026, an estimated $1.87M.
- Intuitive Surgical made up 0.03% of Wealthfront Advisers's portfolio in Q2 2026, its #185 holding.
- Wealthfront Advisers first reported a position in Intuitive Surgical in Q4 2018 and has held it in 31 quarters since.
- Wealthfront Advisers's Intuitive Surgical position peaked at $26.2M in Q4 2025.
- 2,251 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.
Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.